Back
HFA Premium Access

DIAMOND Trial: Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for Heart Failure with Reduced Ejection Fraction

Session: Late-Breaking Trials - Pharmacological treatment II
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Speaker: Professor B. Pitt (Ann Arbor, US)
Event: Heart Failure 2022

Congress Presentation

About the speaker

Professor Bertram Pitt

University of Michigan, Ann Arbor (United States of America)
24 presentations
0 follower

4 more presentations in this session

The safety and efficacy of istaroxime for PreCardiogenic Shock

Speaker: Professor M. Metra (Brescia, IT)

Access
Slides
Video
Thumbnail

Short-term effects of dapagliflozin on peak VO2 in heart failure and reduced ejection fraction (DAPA-VO2): a randomized clinical trial

Speaker: Doctor J. Nunez Villota (Valencia, ES)

Access
Slides
Video
Thumbnail

EMPULSE - EMPagliflozin in patients hospitalized with acUte heart faiLure who have been StabilizEd

Speaker: Professor P. Ponikowski (Wroclaw, PL)

Access
Slides
Video
Thumbnail

FIDELITY: Effect of finerenone by LVH subgroup

Speaker: Professor G. Filippatos (Athens, GR)

Access
Slides
Video
Thumbnail

Access the full session

Late-Breaking Trials - Pharmacological treatment II

Speakers: Professor B. Pitt, Professor M. Metra, Doctor J. Nunez Villota, Professor P. Ponikowski, Professor G. Filippatos
Access
Video
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb